Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies-Reference-Cited by-同舟云学术

Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies

Published:2016-06-10 Issue:29 Volume:7 Page:45283-45301
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Qi Xingshun¹,Li Jianjun²,Deng Han¹,Li Hongyu¹,Su Chunping³,Guo Xiaozhong¹

Affiliation:

1. Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, Liaoning 110840, China

2. Department of Radiotherapy, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China

3. Library of Fourth Military Medical University, Xi'an, Shaanxi 710032 China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives;Discover Oncology;2024-07-03

2. Prognostic Value of Combined Neutrophil-to-Lymphocyte Ratio and Imaging Tumor Capsule in Solitary Hepatocellular Carcinoma Patients after Narrow-Margin Hepatectomy;Journal of Clinical Medicine;2024-01-08

3. Novel Clinical prognostic model to predict survival in hepatocellular carcinoma after LR or LT should be considered including biological characteristics and inflammation score;2023-10-17

4. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review;Frontiers in Oncology;2023-10-04

5. Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice;Cancers;2023-08-30